Consumer Alert: MDL No. 2244 Established for DePuy Pinnacle Hip Implant Cases Claiming Premature Failure

June 1, 2011

DePuy Orthopaedics, Inc. is facing public scrutiny regarding the reportedly premature loosening and failure of its Pinnacle hip prostheses. Within the past year alone, the FDA has received hundreds of adverse reports regarding failures or other complications related to the Pinnacle device.^{^[1]} Patients who experience a premature failure of their hip prostheses typically require surgery to remove the failed hip replacement, placement of a new prostheses, as well as rehabilitation associated with this major surgery.

Many lawsuits involving failed Pinnacle hip implants have already been filed in both state and federal courts across the country. On May 24th, the Judicial Panel on Multidistrict Litigation ("JPMDL") established MDL No. 2244 devoted to litigation surrounding the DePuy Pinnacle hip implants.^{^[2]} The JPMDL has assigned In Re: DePuy Orthopaedics, Inc. Pinnacle Hip Implant Products Liability Litigation to Judge Kinkeade in the Northern District of Texas. DePuy Orthopaedics, Inc. is a unit of Johnson & Johnson.

Robins, Kaplan, Miller & Ciresi L.L.P. is currently litigating Pinnacle cases. If you or a loved one believe you may have received one of DePuy Pinnacle hip implants and are experiencing problems with it, please feel free to contact our offices at 1.800.553.9910, or contact us here.

[1] See FDA MAUDE Database, available at http://www.accessdata.fda.gov/scripts/cdrh/cfdocs/cfMAUDE/TextResults.cfm?dls=101&q=Pinnacle&pf=Data_Date_Year:2011,Data_Date_Year:2010&pn=10&sc=.
[2] See United States Judicial Panel on Multidistrict Litigation, Transfer Order, available at http://www.jpml.uscourts.gov/MDL-2244-Initial_Transfer.pdf

+ READ MORE - READ LESS

The articles on our website include some of the publications and papers authored by our attorneys, both before and after they joined our firm. The content of these articles should not be taken as legal advice. The views and opinions expressed in this article are those of the author(s) and do not necessarily reflect the views or official position of Robins Kaplan LLP.

Disclaimer